Gizmodo: Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ... PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression.
The hallucinogenic drug is an option when traditional treatment isn’t ... AOL: FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a standalone ...
nasal spray ketamine, Please provide your email address to receive an email when new articles are posted on . Depressive symptoms improved within 24 hours of the first dose of esketamine nasal spray. Common adverse effects ... Major depressive disorder affects an estimated 8.3% of the adult population. And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to give rapid relief to depression ...
